NCT04268745

Brief Summary

The specific aims of this pilot project are: Aim #1: Determine the extent to which sensory integration strategies differ between 28 individuals with unilateral vestibular hypofunction and 28 age-matched peers. Participants' postural sway will be recorded as they experience two levels of moving stars10 and white noise, while standing on the floor or a compliant surface. Our working hypothesis is that patients with vestibular hypofunction utilize substitution strategies such that they will demonstrate greater visual and auditory reliance compared with controls, particularly when somatosensory cues are reduced via the support surface. We will then explore whether these mechanism changes after training. Aim #2: Develop the protocol and establish the feasibility of a randomized controlled trial (RCT) comparing C.S.I. training to standard vestibular rehabilitation. Following the assessment, the 28 patients will be randomized into standard vestibular rehabilitation vs. C.S.I. training. This pilot study will enable us to test the feasibility of our recruitment, randomization procedures, establish attrition rate, and test the training protocol. Aim #3: Generate pilot data for sample size calculation for a properly powered RCT. The follow up RCT will test the effect of C.S.I. training on: Visual Vertigo Analog Scale (VVAS), Functional Gait Analysis (primary); balance confidence, overall disability (descriptive). In our preliminary study, 8 patients met the inclusion criteria for the current proposal. Following the C.S.I. training, they had a large effect size of 1.17 on the VVAS. The current study will allow us to identify the between-group effect size for the VVAS and for a functional gait outcome.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2019

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 21, 2019

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

January 24, 2020

Completed
20 days until next milestone

First Posted

Study publicly available on registry

February 13, 2020

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 15, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 23, 2022

Completed
1.6 years until next milestone

Results Posted

Study results publicly available

December 15, 2023

Completed
Last Updated

December 15, 2023

Status Verified

May 1, 2022

Enrollment Period

2.7 years

First QC Date

January 24, 2020

Results QC Date

September 20, 2023

Last Update Submit

December 13, 2023

Conditions

Outcome Measures

Primary Outcomes (3)

  • Visual Vertigo Analog Scale (VVAS)

    The Visual Vertigo Analogue Scale (VVAS) is a self-reported questionnaire where a participant rates their visual vertigo on a 10 cm line in 9 different visually challenging environments. A score of 0 indicates no dizziness. Maximal score is 100 (calculated as the measurement on each item X 9 divided by 10). A higher score indicates worse outcome.

    baseline and 8 weeks

  • Functional Gait Analysis (FGA)

    A functional test designed to assess individual's ability to perform various motor tasks, such as: walking with eyes closed, walking backwards, climbing stairs. There are 10 items, each is scored by a therapist on a scale of 0 (severe impairment) to 3 (normal). Maximal score is 30. Higher is better.

    baseline and 8 weeks

  • The Dizziness Handicap Inventory (DHI)

    The DHI has 25 items and each item is scored as 'no', 'sometimes' or 'yes' to evaluate self-perceived disability imposed by dizziness. The minimum score is 0 and the maximum score is 100, a higher score indicates increased perceived disability. The scale is no = 0, sometimes = 2, and yes = 4.

    baseline and 8 weeks

Secondary Outcomes (3)

  • The Activities Balance Confidence Scale

    baseline and 8 weeks

  • Timed-Up and Go

    baseline and 8 weeks

  • The Four-Step Square Test

    baseline and 8 weeks

Study Arms (2)

Virtual Reality

EXPERIMENTAL

Progressive immersive training with the virtual reality app Scenes: start from most salient to the patient, eventually do all Duration: start at 60 seconds, increase over time up to 3 minutes per scene Complexity: start minimal, gradually increase up to most complex Tasks: standing with diverse base of support (BOS), head turns (progress with speed, planes); stepping, turning 8 weeks, 1 visit per week, 30 minutes long In home: Gait and balance exercises, No exercises with eyes closed, 8 weeks, 6 times per week, twice per day, 10 minutes long

Behavioral: Balance training

Traditional Vestibular Rehabilitation

ACTIVE COMPARATOR

Progressive gait, gaze stability and balance exercises Gait: walking with head turns, progress with range, speed and planes of head movement; change of walking BOS: wide, normal, tandem Gaze: focus on a target while moving head side to side / up down. Progress with speed, duration, busier background, standing to walking. Balance: standing balance tasks, progress with BOS (wide to narrow to tandem), support surface, eyes closed, duration, head turns. 8 weeks, 1 visit per week, 30 minutes long In home: Gait, gaze stability and balance exercises, including exercises with eyes closed, 8 weeks, 6 times per week, twice per day, 10 minutes long

Behavioral: Traditional Vestibular Rehabilitation

Interventions

Progressive balance training within virtual environments

Also known as: Virtual reality, Contextual sensory integration training, HTC Vive
Virtual Reality

Progressive balance training and gaze stability exercises

Traditional Vestibular Rehabilitation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients (18 or older)
  • Clinical diagnosis of chronic (3 months and longer) unilateral peripheral vestibular hypofunction
  • Patients will be included based on the presence of a positive head thrust test, head shaking nystagmus, spontaneous nystagmus, and/or canal paresis \> 25% if a caloric test is available.
  • Included patients must present with at least two positive items on the VVAS

You may not qualify if:

  • Patients will be excluded for prior vestibular rehab, bilateral or unstable vestibular loss or another neurological condition, active benign paroxysmal positional vertigo, acute orthopaedic injuries, peripheral neuropathy, hearing impairment, or visual impairment not corrected with glasses.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

New York Eye and Ear Infirmary of Mount Sinai

New York, New York, 10010, United States

Location

New York University Physical Therapy Department

New York, New York, 10010, United States

Location

Related Publications (2)

  • Kelly J, Harel D, Krishnamoorthy S, Fu G, Morris B, Medlin A, Mischinati S, Wang Z, Sutera J, Perlin K, Cosetti M, Lubetzky AV. Contextual sensory integration training vs. traditional vestibular rehabilitation: a pilot randomized controlled trial. J Neuroeng Rehabil. 2023 Aug 12;20(1):104. doi: 10.1186/s12984-023-01224-6.

  • Lubetzky AV, Harel D, Krishnamoorthy S, Fu G, Morris B, Medlin A, Wang Z, Perlin K, Roginska A, Cosetti M, Kelly J. Decrease in head sway as a measure of sensory integration following vestibular rehabilitation: A randomized controlled trial. J Vestib Res. 2023;33(3):213-226. doi: 10.3233/VES-220107.

MeSH Terms

Conditions

Vertigo

Condition Hierarchy (Ancestors)

Vestibular DiseasesLabyrinth DiseasesEar DiseasesOtorhinolaryngologic DiseasesNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Limitations and Caveats

Small pilot RCT; high dropout rate due to COVID 19 pandemic

Results Point of Contact

Title
Dr. Anat Lubetzky
Organization
New York University

Study Officials

  • Anat Lubetzky, PhD

    New York University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 24, 2020

First Posted

February 13, 2020

Study Start

August 21, 2019

Primary Completion

April 15, 2022

Study Completion

May 23, 2022

Last Updated

December 15, 2023

Results First Posted

December 15, 2023

Record last verified: 2022-05

Data Sharing

IPD Sharing
Will not share

Locations